academic article

• A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases..  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.  32:1834-1846. 2019
• Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. 2017
• PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS..  Journal of medical genetics.  53:800-811. 2016
• A targeted genetic association study of epithelial ovarian cancer susceptibility..  Oncotarget.  7:7381-7389. 2016
• Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk..  Genetic epidemiology.  :-. 2015
• Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  :-. 2015
• Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study..  Gynecologic oncology.  136:542-548. 2015
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer. 2015
• Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer..  Nature communications.  6:-. 2015
• Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. 2015
• Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel..  Human molecular genetics.  22:3038-3047. 2013
• Assessment of hepatocyte growth factor in ovarian cancer mortality..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  20:1638-1648. 2011
• Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers..  PloS one.  6:-. 2011